Cite
Ichikawa S, Fukuhara N, Inoue A, et al. Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis. Exp Hematol Oncol. 2013;2(1):19doi: 10.1186/2162-3619-2-19.
Ichikawa, S., Fukuhara, N., Inoue, A., Katsushima, H., Ohba, R., Katsuoka, Y., Onishi, Y., Yamamoto, J., Sasaki, O., Nomura, J., Fukuhara, O., Ishizawa, K., Ichinohasama, R., & Harigae, H. (2013). Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis. Experimental hematology & oncology, 2(1), 19. https://doi.org/10.1186/2162-3619-2-19
Ichikawa, Satoshi, et al. "Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis." Experimental hematology & oncology vol. 2,1 (2013): 19. doi: https://doi.org/10.1186/2162-3619-2-19
Ichikawa S, Fukuhara N, Inoue A, Katsushima H, Ohba R, Katsuoka Y, Onishi Y, Yamamoto J, Sasaki O, Nomura J, Fukuhara O, Ishizawa K, Ichinohasama R, Harigae H. Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis. Exp Hematol Oncol. 2013 Aug 02;2(1):19. doi: 10.1186/2162-3619-2-19. PMID: 23915571; PMCID: PMC3750298.
Copy
Download .nbib